Dr Reddys Laboratories (RDY) EBT Margin Growth (1y) (2010 - 2026)
Powered by 
Analysis
Dr Reddys Laboratories (RDY) EBT Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | -1,585.00 |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | 436.00 |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -1,544.00 |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 178.00 |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | 667.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -13,174.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 896.00 |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | -159.00 |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | 4,393.00 |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,544.00 |
| Mar 31, 2026 | -2,093.00 |
| Dec 31, 2025 | -474.00 |
| Sep 30, 2025 | -307.00 |
| Jun 30, 2025 | -224.00 |
| Mar 31, 2025 | 96.00 |
| Dec 31, 2024 | -288.00 |
| Sep 30, 2024 | -390.00 |
| Jun 30, 2024 | -325.00 |
| Mar 31, 2024 | -476.00 |
| Dec 31, 2023 | 418.00 |
| Sep 30, 2023 | 366.00 |
| Jun 30, 2023 | -32.00 |
| Mar 31, 2023 | 2,281.00 |
| Dec 31, 2022 | 982.00 |
| Sep 30, 2022 | 589.00 |
| Jun 30, 2022 | 609.00 |
| Mar 31, 2022 | -1,052.00 |
| Dec 31, 2021 | -573.00 |
| Sep 30, 2021 | 1,247.00 |